Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. Posted 48.4 Million Yuan Net Loss in First Three Quarters of 2022

Jiangsu Wuzhong Pharmaceutical Development Co.,Ltd. (江苏吴中医药发展股份有限公司) (600200.SH) reported a net loss of 48.4 million yuan in the first three quarters of 2022, reversing a net profit of 47.9 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 6% year-on-year.

At the end of the reporting period, it had 3.8 billion yuan in total assets and 2 billion yuan in total liabilities, with a liability-to-asset ratio of 51.7%.